Advisory Services Network’s Standard BioTools LAB Stock Holding History

Advisory Services Network’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,490	Closed	-$5.97K	–	3539
2026 Q1	$5.97K	Buy	+6,490	New	+$7.86K	﹤0.01%	3775
2025 Q4	–	Sell	-6,490	Closed	-$8.44K	–	3189
2025 Q3	$8.44K	Buy	+6,490	New	+$8.5K	﹤0.01%	3351
2024 Q1	–	Sell	-500	Closed	-$1.1K	–	2670
2023 Q4	$1.1K	Buy	+500	New	+$1.07K	﹤0.01%	3512
2023 Q2	–	Sell	-500	Closed	-$975	–	2649
2023 Q1	$975	Hold	500	–	–	﹤0.01%	3621
2022 Q4	$585	Buy	+500	New	+$616	﹤0.01%	3711

Other funds holding LAB

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $504M AUM 26.89% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Advisory Services Network's LAB Position: Q2 2026 in Review

Advisory Services Network sold out of Standard BioTools (LAB) in Q2 2026, closing a stake of 6,490 shares — an estimated $5.97K sold.

Advisory Services Network first reported a position in LAB in Q4 2022 and held it in 5 quarters. The position peaked at $8.44K in Q3 2025. 144 funds tracked by Wall St. Rank hold LAB as of Q2 2026.

Advisory Services Network reported no remaining Standard BioTools position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 6,490 Standard BioTools shares in Q2 2026, an estimated $5.97K.
Advisory Services Network first reported a position in Standard BioTools in Q4 2022 and held it in 5 quarters.
Advisory Services Network's Standard BioTools position peaked at $8.44K in Q3 2025.
144 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.